1,074 results on '"Buhl, Roland"'
Search Results
2. Asthma in Klinik und Praxis
3. MASK-air: An OECD (Organisation for Economic Co-operation and Development) Best Practice for Public Health on Integrated Care for Chronic Diseases
4. Poor Rhinitis and Asthma Control Is Associated With Decreased Health-Related Quality of Life and Utilities: A MASK-air Study
5. In ‘real world’ patients with COPD, exacerbation history, and not blood eosinophils, is the most reliable predictor of future exacerbations
6. Key recommendations for primary care from the 2022 Global Initiative for Asthma (GINA) update
7. EVELUT®: A Real-World, Observational Study Assessing Dyspnoea and Symptom Burden in COPD Patients Switched from LABA/ICS to LAMA/LABA or LAMA/LABA/ICS
8. German Asthma Net – Was haben wir bisher gelernt?
9. Initiation, response assessment, and switch of antibody therapies in patients with severe asthma – A survey among German specialists
10. Characterization of Austrian severe asthma patients
11. Characterization of Obesity in Severe Asthma in the German Asthma Net
12. Global access and patient safety in the transition to environmentally friendly respiratory inhalers: the Global Initiative for Asthma perspective
13. Response to Biologics and Clinical Remission in the Adult German Asthma Net Severe Asthma Registry Cohort
14. Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo-controlled extension study
15. Development and validation of an electronic daily control score for asthma (e-DASTHMA): a real-world direct patient data study
16. Impact of donor lung quality on post‐transplant recipient outcome in the Lung Allocation Score era in Eurotransplant – a historical prospective study
17. German asthma net: Nasal polyposis in patients in the severe asthma registry
18. Thoracic skeletal muscle mass predicts mortality in patients with surgery for pleural empyema: A case control study
19. Overall Response to Anti-IL-5/Anti-IL5-Rα Treatment in Severe Asthma Does Not Depend on Initial Bronchodilator Responsiveness
20. Is Inhaler Technique Adequately Assessed and Reported in Clinical Trials of Asthma and Chronic Obstructive Pulmonary Disease Therapy? A Systematic Review and Suggested Best Practice Checklist
21. Disease-modifying anti-asthmatic drugs
22. The German severe asthma patient: Baseline characteristics of patients in the German Severe Asthma Registry, and relationship with exacerbations and control
23. Impact of switching from triple therapy to dual bronchodilation in COPD: the DACCORD ‘real world’ study
24. Effective Management of Severe Asthma with Biologic Medications in Adult Patients: A Literature Review and International Expert Opinion
25. Global Initiative for Asthma Strategy 2021: Executive Summary and Rationale for Key Changes
26. As-needed low-dose inhaled corticosteroid/formoterol therapy in patients with severe asthma included in the German Asthma Net cohort
27. Poor rhinitis and asthma control is associated with decreased health-related quality-of-life and utilities: A MASK-air study
28. MASK-air®: An OECD (Organisation for Economic Coordination and Development) Best Practice for Public Health on integrated care for chronic diseases.
29. Returning to work in lung cancer survivors—a multi-center cross-sectional study in Germany
30. Clinical Development of Mepolizumab for the Treatment of Severe Eosinophilic Asthma: On the Path to Personalized Medicine
31. Chronisch-obstruktive Lungenerkrankung 2021 – die richtige Therapie für den richtigen Patienten
32. Tezepelumab in patients with allergic and eosinophilic asthma.
33. Prospective, Single-Arm, Longitudinal Study of Biomarkers in Real-World Patients with Severe Asthma
34. Age- and sex-dependent differences in patients with severe asthma included in the German Asthma Net cohort
35. One-year follow up of asthmatic patients newly initiated on treatment with medium- or high-dose inhaled corticosteroid-long-acting β2-agonist in UK primary care settings
36. Tezepelumab in patients with allergic and eosinophilic asthma
37. Pioneering a paradigm shift in asthma management: remission as a treatment goal
38. Tiotropium/Olodaterol Decreases Exacerbation Rates Compared with Tiotropium in a Range of Patients with COPD: Pooled Analysis of the TONADO®/DYNAGITO® Trials
39. Efficacy of Tiotropium/Olodaterol Compared with Tiotropium as a First-Line Maintenance Treatment in Patients with COPD Who Are Naïve to LAMA, LABA and ICS: Pooled Analysis of Four Clinical Trials
40. COPD Assessment Test Changes from Baseline Correlate with COPD Exacerbations: A Longitudinal Analysis of the DACCORD Observational Study
41. Benefits of Tiotropium/Olodaterol Compared with Tiotropium in Patients with COPD Receiving only LAMA at Baseline: Pooled Analysis of the TONADO® and OTEMTO® Studies
42. ARIA guideline 2019: treatment of allergic rhinitis in the German health system
43. Use of psychosocial services by lung cancer survivors in Germany: Results of a German multicenter study (LARIS)
44. Assessment of the long-term safety of mepolizumab and durability of clinical response in patients with severe eosinophilic asthma
45. Omalizumab as alternative to chronic use of oral corticosteroids in severe asthma
46. Quality of Life in NSCLC Survivors — A Multicenter Cross-Sectional Study
47. Development of the International Severe Asthma Registry (ISAR): A Modified Delphi Study
48. Effect of long-acting β2-agonists olodaterol and formoterol on heart rate and blood pressure in chronic obstructive pulmonary disease patients
49. Tiotropium add-on to inhaled corticosteroids versus addition of long-acting β2-agonists for adults with asthma
50. Safety of tiotropium/olodaterol in chronic obstructive pulmonary disease: pooled analysis of three large, 52-week, randomized clinical trials
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.